NCT00330577已完成4 期
24-Hour Intraocular Pressure (IOP) And Blood Pressure Control In Glaucoma And Ocular Hypertension Patients
适应症
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 30
- 试验地点
- 2
研究概览
简要总结
The purpose of this study is to compare the short-term mean 24-hour intraocular pressure control, 24-hour blood pressure effect and safety of Latanoprost/Timolol fixed combination given once in the evening with placebo once in the morning versus timolol maleate 0.5% given twice daily in patients with ocular hypertension and primary open-angle glaucoma.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 29 Years 至 80 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- •Advanced glaucoma
- •Arterial Hypertension
研究者
AGP Konstas
Professor in Ophthalmology
Aristotle University Of Thessaloniki
研究点 (2)
Loading locations...
相似试验
已完成
3 期
24-Hour Intraocular Pressure (IOP) Control With Travoprost/Timolol Fixed CombinationPrimary Open Angle GlaucomaExfoliation SyndromeNCT00331240Aristotle University Of Thessaloniki32
已完成
4 期
24-Hour Intraocular Pressure Control With Bimatoprost/Timolol Versus Latanoprost as First ChoiceGlaucomaNCT01448837Aristotle University Of Thessaloniki37
已完成
4 期
24-hour Control of Intraocular Pressure (IOP) in Ocular HypertensionOcular HypertensionNCT01655758University of Parma61
已完成
不适用
IOP Device Comparison StudyIntraocular PressureNCT04211792Lawson Health Research Institute101
终止
不适用
Intraocular Pressure (IOP) Patterns in Fast Versus Slow Visual Field (VF) Progression PatientsPrimary Open-angle Glaucoma (POAG) PatientNCT01828255Sensimed AG40